A detailed history of Golden State Equity Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 740 shares of MRK stock, worth $73,778. This represents 0.05% of its overall portfolio holdings.

Number of Shares
740
Previous 31,426 97.65%
Holding current value
$73,778
Previous $3.57 Million 97.65%
% of portfolio
0.05%
Previous 0.81%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$111.15 - $128.97 $3.41 Million - $3.96 Million
-30,686 Reduced 97.65%
740 $84,000
Q3 2024

Oct 25, 2024

BUY
$111.15 - $128.97 $343,342 - $398,388
3,089 Added 10.9%
31,426 $3.57 Million
Q2 2024

Jul 29, 2024

SELL
$123.8 - $132.96 $61,157 - $65,682
-494 Reduced 1.71%
28,337 $3.51 Million
Q4 2023

Feb 02, 2024

SELL
$100.18 - $109.02 $6,812 - $7,413
-68 Reduced 0.24%
28,831 $3.14 Million
Q3 2023

Oct 20, 2023

SELL
$102.95 - $114.33 $13,795 - $15,320
-134 Reduced 0.46%
28,899 $2.98 Million
Q2 2023

Jul 19, 2023

BUY
$108.61 - $118.38 $710,092 - $773,968
6,538 Added 29.06%
29,033 $3.35 Million
Q1 2023

Jun 01, 2023

BUY
$102.94 - $114.86 $26,661 - $29,748
259 Added 1.16%
22,495 $2.39 Billion
Q1 2022

May 18, 2022

BUY
$73.51 - $82.4 $23,964 - $26,862
326 Added 1.49%
22,236 $1.82 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $587,050 - $658,046
-7,986 Reduced 26.71%
21,910 $1.69 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $786,117 - $984,713
10,876 Added 57.18%
29,896 $2.29 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $95,621 - $105,159
-1,334 Reduced 6.55%
19,020 $1.43 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $109,402 - $121,010
-1,556 Reduced 7.1%
20,354 $1.58 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $208,232 - $245,276
3,024 Added 16.01%
21,910 $1.69 Million
Q4 2020

Feb 08, 2021

BUY
$71.77 - $79.65 $1.36 Million - $1.5 Million
18,886 New
18,886 $1.54 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.